The Australian market has seen mixed performance recently, with the ASX200 closing up 0.39% at 8,013 points driven by gains in financials but weighed down by energy and mining stocks due to falling commodity prices. In this fluctuating environment, identifying promising small-cap stocks with strong fundamentals and growth potential becomes crucial for investors seeking hidden opportunities.
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Fiducian Group | NA | 9.94% | 6.48% | ★★★★★★ |
Lycopodium | NA | 17.22% | 33.85% | ★★★★★★ |
Bailador Technology Investments | NA | 11.17% | 10.16% | ★★★★★★ |
Sugar Terminals | NA | 2.34% | 2.64% | ★★★★★★ |
BSP Financial Group | 7.53% | 7.31% | 4.10% | ★★★★★☆ |
Steamships Trading | 33.60% | 4.17% | 3.90% | ★★★★★☆ |
AMCIL | NA | 5.16% | 5.31% | ★★★★★☆ |
Hearts and Minds Investments | 1.00% | 18.81% | 20.95% | ★★★★☆☆ |
A2B Australia | 15.83% | -7.78% | 25.44% | ★★★★☆☆ |
Boart Longyear Group | 71.20% | 9.71% | 39.19% | ★★★★☆☆ |
Click here to see the full list of 51 stocks from our ASX Undiscovered Gems With Strong Fundamentals screener.
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Value Rating: ★★★★★★
Overview: Redox Limited supplies and distributes chemicals, ingredients, and raw materials in Australia, New Zealand, the United States, and internationally with a market cap of A$1.61 billion.
Operations: Redox generates revenue primarily from its wholesale drugs segment, amounting to A$1.14 billion.
Redox has seen a robust 18.3% annual earnings growth over the past five years, with its debt-to-equity ratio significantly dropping from 69.6% to 2.6%. Trading at 17.2% below its estimated fair value, Redox's net income for FY2024 was A$90.24 million, up from A$80.73 million last year despite sales dipping to A$1,137.33 million from A$1,257.52 million in FY2023. The company also declared a fully franked final dividend of 6.5 cents per share for the year ended June 30, 2024.
Gain insights into Redox's past trends and performance with our Past report.
Simply Wall St Value Rating: ★★★★★☆
Overview: Ricegrowers Limited, with a market cap of A$559.39 million, operates as a rice food company serving markets in Australia, New Zealand, the Pacific Islands, the Middle East, the United States, and internationally.
Operations: Ricegrowers Limited generates revenue primarily from its International Rice segment (A$894.03 million) and Rice Pool segment (A$498.11 million), with additional contributions from Cop Rice (A$252.75 million) and Riviana (A$222.01 million). The company also reports revenue from its Corporate Segment amounting to A$45.79 million and the Rice Food segment at A$121.03 million, after accounting for intersegment eliminations of -A$159.53 million.
Ricegrowers, known for its SunRice brand, reported a net income of A$63.14 million for FY2024, up from A$52.55 million the previous year. The company’s earnings growth of 20.1% outpaced the broader food industry and it trades at 65.7% below estimated fair value, suggesting potential undervaluation. With a satisfactory net debt to equity ratio of 34%, Ricegrowers is actively seeking strategic acquisitions both domestically and internationally to bolster its growth trajectory further.
Examine Ricegrowers' past performance report to understand how it has performed in the past.
Simply Wall St Value Rating: ★★★★★★
Overview: Tasmea Limited offers shutdown, maintenance, emergency breakdown, and capital upgrade services in Australia with a market cap of A$406.36 million.
Operations: Tasmea Limited generates revenue from five primary segments: Water & Fluid (A$73.55 million), Civil Services (A$53.64 million), Corporate Services (A$1.94 million), Electrical Services (A$129.44 million), and Mechanical Services (A$141.42 million).
Tasmea's net debt to equity ratio of 25.3% is satisfactory, and its interest payments are well covered by EBIT at 12x. The company reported impressive growth with earnings up by 57.1% over the past year, outpacing the Construction industry's 19.5%. Recent earnings showed sales of A$400 million and net income of A$30.35 million for FY2024, compared to A$319.98 million and A$19.32 million last year respectively, reflecting strong performance and a promising outlook with forecasted annual growth at 21.82%.
Evaluate Tasmea's historical performance by accessing our past performance report.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:RDX ASX:SGLLV and ASX:TEA.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。